Skip to main content

Advertisement

Log in

Angiotensin AT1 Receptors and Their Ligands (Review)

  • MOLECULAR BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This review addresses on the most intensely studied biological targets in the body – type 1 angiotensin receptors. Particular attention is focused on receptor structure and its interaction with various intracellular signal molecules. Data on long-known and newly created ligands able to influence AT1 receptors are presented. The individual structural fragments of AT1 antagonist molecules with functional significance for this type of activity are described. The review includes a brief analysis of the potentials for the clinical use of AT1 antagonists in a number of pathological states additional to the registered indications, including arterial hypertension, chronic heart failure, and nephropathy in type 2 diabetes mellitus. These results from the discovery of additional aspects of the mechanism of action of antagonists and their ability to produce effects such as neuroprotective and anti-inflammatory actions, as well as various organ-protective properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. L. Hunyady and K. J. Catt, Molec. Endocrinol., 20(5), 953 – 970 (2006).

    Article  CAS  Google Scholar 

  2. P. K. Mehta and K. K. Griendling, Am. J. Physiol. Cell. Physiol., 292(1), 82 – 97 (2007).

    Article  Google Scholar 

  3. R. M. Touyz, Braz. J. Med. Biol. Res., 37(8), 1263 – 1273 (2004).

    Article  CAS  PubMed  Google Scholar 

  4. C. Dasgupta and L. Zhang, Drug. Discov. Today, 16(1), 22 – 34 (2011).

    Article  CAS  PubMed  Google Scholar 

  5. D. T. Dihn, A. G. Frauman, C. I. Jonston, and M. E. Fabiani, Clin. Sci., 100(5), 481 – 492 (2001).

    Article  Google Scholar 

  6. S. V. Terent’eva, E. N. Komarova, T. N. Sapozhnikova, et al., Khim-Farm. Zh., 40(12), 54 – 56 (2006); Pharm. Chem. J., 40(12), (2006).

  7. M. De Gasparo, K. J. Catt, T. Inagami, et al., Pharmacol. Rev., 52(3), 415 – 472 (2000).

    CAS  PubMed  Google Scholar 

  8. C. A. Lemarie and E. L. Schiffrin, J. Renin-Angiotensin-Aldosterone Syst., 11(1), 19 – 31 (2010).

    Article  CAS  PubMed  Google Scholar 

  9. O. V. Shevchenko, A. A. Svistunov, V. B. Borodulin, et al., Saratov. Nauch.-Med. Zh., 7(1), 83 – 87 (2011).

    CAS  Google Scholar 

  10. M. Jira, E. Zavodna, N. Honzikova, et al., Physiol. Res., 59(4), 517 – 528 (2010).

    CAS  PubMed  Google Scholar 

  11. P. P. Van Geel, Y. M. Pinto, A. A. Voors, et al., Hypertension, 35(3), 717 – 721 (2000).

    Article  CAS  PubMed  Google Scholar 

  12. S. Miura, S. S. Karnik, and K. Saku, J. Renin-Angiotensin-Aldosterone Syst., 12(1), 1 – 7 (2011).

    Article  CAS  PubMed  Google Scholar 

  13. L. Yan, B. J. Holleran, P. Lavigne, et al., J. Biol. Chem., 285(4), 2284 – 2293 (2010).

    Article  CAS  PubMed  Google Scholar 

  14. D. F. Guo, Y. L. Sun, P. Hamet, and T. Inagami, Cell Res., 11(3), 165 – 180 (2001).

    Article  CAS  PubMed  Google Scholar 

  15. M. Yamada, M. Kushibiki, T. Osanai, et al., Cardiovasc. Res., 79(1), 169 – 178 (2008).

    Article  CAS  PubMed  Google Scholar 

  16. J. L. Hansen, J. Theilade, S. Haunso, and S. P. Sheikh, J. Biol. Chem., 279(23), 24108 – 24115 (2004).

    Article  CAS  PubMed  Google Scholar 

  17. S. Guimaraes and H. Pinheiro, Cardiovasc. Res., 67(2), 208 – 215 (2005).

    Article  CAS  PubMed  Google Scholar 

  18. E. Kaschina and T. Unger, Blood Pressure, 12(2), 70 – 88 (2003).

    Article  CAS  PubMed  Google Scholar 

  19. N. Asano, T. Ogura, Y. Mimura, et al., Res. Common. Mol. Pathol. Pharmacol., 100(2), 161 – 170 (1998).

    CAS  Google Scholar 

  20. H. M. Siragy, Am. J. Kidney. Dis., 36(3) Suppl. 1, 4 – 9 (2000).

  21. H. M. Siragy and R. M. Carey, Am. J. Nephrol., 31(6), 541 – 550 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. P. D. Bell and J. Peti-Peterdi, J. Am. Soc. Nephrol., 10, Supplement 11, 225 – 229 (1999).

  23. P. R. Saxena, J. Cardiovasc. Pharmacol., 19, (Suppl. 6), 80 – 88 (1992).

    Article  Google Scholar 

  24. A. I. De Gois Queiroz, C. D. Medeiros, B. M. Ribeiro, et al., Med. Hypotheses, 80(3), 259 – 263 (2013).

    Article  CAS  PubMed  Google Scholar 

  25. M. Paul, A. Poyan Mehr, and R. Kreutz, Physiol. Rev., 86(3), 747 – 803 (2006).

    Article  CAS  PubMed  Google Scholar 

  26. E. G. Krause, S. J. Melhorn, J. F. Davis, et al., Endocrinology, 149(12), 6416 – 6424 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. M. Macova, J. Pavel, and J. M. Saavedra, Brain. Res., 1250, 130 – 140 (2009).

    Article  CAS  PubMed  Google Scholar 

  28. J. M. Saaverda, M. Viswanathan, and K. Shigematsu, Eur. J. Pharmacol., 235(2 – 3), 301 – 303 (1993).

    Google Scholar 

  29. A. M. Allen, H. Yamada, and F. A. Mendelsohn, Int. J. Cardiol., 28(1), 25 – 33 (1990).

    Article  CAS  PubMed  Google Scholar 

  30. L. A. Sechi, C. A. Griffin, E. F. Grady, et al., Circ. Res., 71(6), 1482 – 1489 (1992).

    Article  CAS  PubMed  Google Scholar 

  31. A. A. Spasov, D. S. Yakovlev, T. M. Bukatina, A. A. Brigadirova, Byull. Éksperim. Biol. Med., 158(7), 128 – 130 (2014).

    Google Scholar 

  32. S. A. Atlas, J. Manag. Care Pharm., 13(8) Suppl. B, 9 – 20 (2007).

  33. S. Higuchi, H. Ohtsu, H. Suzuki, et al., Clin. Sci., 112(8), 417 – 428 (2007).

    Article  CAS  PubMed  Google Scholar 

  34. Y. Numaguchi, M. Ishii, R. Kubota, et al., Arterioscler. Thromb. Vasc. Biol., 29(12), 2102 – 2108 (2009).

    Article  CAS  PubMed  Google Scholar 

  35. J. W. Wright, S. Mizutani, and J. W. Harding, Int. J. Hypertens., 2012, Article ID 124758, 1 – 12 (2012).

  36. S. D. Kivlighn, W. R. Huckle, G. J. Zingaro, et al., Am. J. Physiol., 268(3), 820 – 823 (1995).

    Google Scholar 

  37. Y. Wan, C. Wallinder, B. Johansson, et al., J. Med. Chem., 47(6), 1536 – 1546 (2004).

    Article  CAS  PubMed  Google Scholar 

  38. M. Alterman, J. Renin-Angiotensin-Aldosterone Syst., 11(1), 57 – 66 (2010).

    Article  CAS  PubMed  Google Scholar 

  39. P. A. Van Zwieten, Neth. Heart J., 14(11), 381 – 387 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  40. G. K. Aulakh, R. K. Sodhi, and M. Singh, Life Sci., 81(8), 615 – 639 (2007).

    Article  CAS  PubMed  Google Scholar 

  41. N. V. Zakharova, S. R. Kuz’mina-Krutetskaya, Sistem. Gipertenzii, 8(3), 10 – 16 (2011).

    Google Scholar 

  42. A. M. Shilov, I. V. Eremina, Trudnyi Patsient, 9(7), 26 – 32 (2011).

    Google Scholar 

  43. A. L. Vertkin, E. V. Adonina, E. I. Zvyagintseva, et al., Rus. Med. Zh., 17(8), 589 – 594 (2009).

    Google Scholar 

  44. V. V. Fomin, M. M. Kurashov, Klin. Nefrol., No. 4, 63 – 70 (2009).

  45. C. M. Ferrario, J. Renin-Angiotensin-Aldosterone Syst., 7(1), 3 – 14 (2006).

    Article  CAS  PubMed  Google Scholar 

  46. G. Agelis, K. Kelaidonis, A. Resvani, et al., Molecules, 18(7), 7510 – 7532 (2013).

    Article  CAS  PubMed  Google Scholar 

  47. P. Jezko and M. Remko, Abstrs. of 2nd Meeting of the Paul Ehrlich MedChem Euro-PhD Network, Slovenia (2012), Abstr. O-6, p. 28.

  48. A. Jain, S. C. Chaturverdi, and R. Sharma, Int. J. Pharm. Pharm. Sci., 3(Suppl. 5), 541 – 546 (2011).

    CAS  Google Scholar 

  49. X. Z. Guo, L. Shi, R. Wang, et al., Bioorg. Med. Chem., 16(24), 10301 – 10310 (2008).

    Article  CAS  PubMed  Google Scholar 

  50. V. A. Anisimova, A. A. Spasov, I. E. Tolpygin, et al., Khim-Farm. Zh., 44(7), 7 – 13 (2010); Pharm. Chem. J., 44(7), 345 – 351 (2010).

  51. V. A. Anisimova, I. E. Tolpygin, A. A. Spasov, et al., Khim-Farm. Zh., 46(6), 3 – 8 (2012); Pharm. Chem. J., 46(6), 399 – 404 (2012).

  52. A. A. Spasov, D. S. Yakovlev, Khim-Farm. Zh., 47(8), 3 – 8 (2013); Pharm. Chem. J., 47(8) (2013).

  53. H. K. Chopra and N. C. Nanda, Textbook of Cardiology (A Clinical and Historical Perspective), JP Medical Ltd, New Delhi (2013), p. 65.

    Book  Google Scholar 

  54. Y. H. Chi, H. J. Lee, J. H. Kim, et al., Biol. Pharm. Bul., 36(7), 1208 – 1215 (2013).

    Article  CAS  Google Scholar 

  55. F. Yamaki, T. Arai, M. Aoyama, et al., J. Pharmacol. Sci., 122(1), 28 – 33 (2013).

    Article  CAS  PubMed  Google Scholar 

  56. M. Ojima, H. Igata, M. Tanaka, et al., J. Pharmacol. Exp. Ther., 336(3), 801 – 808 (2011).

    Article  CAS  PubMed  Google Scholar 

  57. P. Balakumar and N. Mahadevan, Int. J. Rec. Adv. Pharm. Res., 2, 11 – 13 (2011).

    Google Scholar 

  58. A. R. De Caterina, A. R. Harper, and F. Cuculi, Vasc. Health Risk Manag., 8, 299 – 305 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. T. W. Kurtz and T. Kajiya, Vasc. Health Risk Manag., 8, 133 – 143 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  60. J. H. Kim, J. H. Lee, S. H. Paik, et al., Arch. Pharm. Res., 35(7), 1123 – 1126 (2012).

    Article  CAS  PubMed  Google Scholar 

  61. J. B. Park, K. C. Sung, S. M. Kang, and E. J. Cho, Am. J. Cardiovasc. Drugs, 13(1), 47 – 56 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. S. Ryu, J. S. Shin, Y. W. Cho, et al., Biol. Pharm. Bul., 36(3), 467 – 474 (2013).

    Article  CAS  Google Scholar 

  63. Yu. N. Belenkov, R. G. Oganov (red.), Cardilogy. National Guidelines: Brief Edition [in Russian], GÉOTAR-Media, Moscow (2012), pp. 320 – 324.

  64. S. V. Nedogoda, A. S. Salasyuk, T. A. Chalyabi, et al., Sistemnye Gipertenzii, 10(2), 27 – 33 (2013).

    Google Scholar 

  65. S. V. Nedogoda, Ter. Arkhiv, 83(10), 45 – 48 (2011).

    Google Scholar 

  66. A. A. Bova, Med. Novosti, 1 6, 11 – 15 (2009).

  67. I. Taguchi, S. Toyoda, K. Takano, et al., Hypertens. Res., 36(7), 608 – 613 (2013).

    Article  CAS  PubMed  Google Scholar 

  68. V. Zidek, P. Mlejnek, M. Simakova, et al., Am. J. Hypertens., 26(6), 829 – 835 (2013).

    Article  CAS  PubMed  Google Scholar 

  69. A. C. Montezano, A. Nguyen Dinh Cat, F. J. Rios, and R. M. Touyz, Cur. Hypertens. Rep., 16(6), 16:431 (2014).

  70. C. Savoia and E. L. Schiffrin, Clin. Sci., 112(7), 375 – 384 (2007).

    Article  CAS  PubMed  Google Scholar 

  71. J. M. Saavedra, E. Sanchez-Lemus, and J. Benicky, Psychoneuroendocrinology, 36(1), 1 – 18 (2011).

    Article  CAS  PubMed  Google Scholar 

  72. T. V. Lanx, Z. Ding, P. P. Ho, et al., J. Clin. Invest., 120(8), 2782 – 2794 (2010).

    Article  Google Scholar 

  73. K. D. Silveira, F. M. Coelho, A. T. Vieira, et al., Peptides, 46, 53 – 63 (2013).

    Article  CAS  PubMed  Google Scholar 

  74. M. I. Phillips and E. M. de Oliveira, J. Mol. Med., 86(6), 715 – 722 (2008).

    Article  CAS  PubMed  Google Scholar 

  75. J. M. Saavedra, Clin. Sci., 123(10), 567 – 590 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. J. Wang, T. Pang, T. Hafko, et al., Neuropharmacology, 79, 249 – 261 (2014).

    Article  CAS  PubMed  Google Scholar 

  77. J. W. Wright and J. W. Harding, Pflügers Arch., 465(1), 133 – 151 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. S. Yakovlev.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spasov, A.A., Yakovlev, D.S. & Brigadirova, A.A. Angiotensin AT1 Receptors and Their Ligands (Review). Pharm Chem J 51, 1–8 (2017). https://doi.org/10.1007/s11094-017-1546-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-017-1546-y

Keywords

Navigation